Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
Published in Nuclear medicine communications
These results suggest that SUV(gluc) may aid in the differentiation of residual or recurrent high-grade tumor from post-treatment changes in patients with abnormal blood glucose levels. The simplicity of the SUV(gluc) avoids the complexity of kinetic analysis or the requirement of a reference tissue.
